A Caltech Library Service

Chemical Genetic Control of Protein Levels: Selective in Vivo Targeted Degradation

Schneekloth, John S., Jr. and Fonseca, Fabiana N. and Koldobskiy, Michael and Mandal, Amit and Deshaies, Raymond and Sakamoto, Kathleen M. and Crews, Craig M. (2004) Chemical Genetic Control of Protein Levels: Selective in Vivo Targeted Degradation. Journal of the American Chemical Society, 126 (12). pp. 3748-3754. ISSN 0002-7863. doi:10.1021/ja039025z.

[img] PDF - Supplemental Material
See Usage Policy.


Use this Persistent URL to link to this item:


Genetic loss of function analysis is a powerful method for the study of protein function. However, some cell biological questions are difficult to address using traditional genetic strategies often due to the lack of appropriate genetic model systems. Here, we present a general strategy for the design and syntheses of molecules capable of inducing the degradation of selected proteins in vivo via the ubiquitin−proteasome pathway. Western blot and fluorometric analyses indicated the loss of two different targets:  green fluorescent protein (GFP) fused with FK506 binding protein (FKBP12) and GFP fused with the androgen receptor (AR), after treatment with PROteolysis TArgeting Chimeric moleculeS (PROTACS) incorporating a FKBP12 ligand and dihydrotestosterone, respectively. These are the first in vivo examples of direct small molecule-induced recruitment of target proteins to the proteasome for degradation upon addition to cultured cells. Moreover, PROTAC-mediated protein degradation offers a general strategy to create “chemical knockouts,” thus opening new possibilities for the control of protein function.

Item Type:Article
Related URLs:
URLURL TypeDescription Information
Deshaies, Raymond0000-0002-3671-9354
Sakamoto, Kathleen M.0000-0003-0494-8838
Additional Information:© 2004 American Chemical Society. Received 13 October 2003. Published online 6 March 2004. Published in print 1 March 2004. J.S.S. thanks the American Chemical Society, Division of Medicinal Chemistry, and Aventis Pharmaceuticals for a predoctoral fellowship. We would like to thank Charles Sawyers (UCLA) for providing the GFP-AR expression plasmid. We thank John Hines for helpful discussions. This work was supported by the NIH (R21 DK63404 to C.M.C.), UCLA SPORE in Prostate Cancer Research (P50 CA92131 to K.M.S.), CaPCURE (R.J.D., C.M.C., and K.M.S.), Department of Defense (DAMD17-03-1-0220 to K.M.S.), UC BioSTAR Project (01-10232 to K.M.S.), Stein-Oppenheimer Award (K.M.S.), and the Susan G. Komen Breast Cancer Foundation (DISS0201703 to R.J.D.). R.J.D. is an Assistant Investigator of the HHMI.
Funding AgencyGrant Number
NIHR21 DK63404
NIHP50 CA92131
Department of DefenseDAMD17-03-1-0220
University of California01-10232
Stein-Oppenheimer AwardUNSPECIFIED
Susan G. Komen Breast Cancer FoundationDISS0201703
Howard Hughes Medical Institute (HHMI)UNSPECIFIED
American Chemical Society, Division of Medicinal ChemistryUNSPECIFIED
Aventis PharmaceuticalsUNSPECIFIED
Issue or Number:12
Record Number:CaltechAUTHORS:20170419-145525640
Persistent URL:
Official Citation:Chemical Genetic Control of Protein Levels:  Selective in Vivo Targeted Degradation John S. Schneekloth, Jr., Fabiana N. Fonseca, Michael Koldobskiy, Amit Mandal, Raymond Deshaies, Kathleen Sakamoto, and Craig M. Crews Journal of the American Chemical Society 2004 126 (12), 3748-3754 DOI: 10.1021/ja039025z
Usage Policy:No commercial reproduction, distribution, display or performance rights in this work are provided.
ID Code:76715
Deposited By: Ruth Sustaita
Deposited On:19 Apr 2017 22:30
Last Modified:15 Nov 2021 17:02

Repository Staff Only: item control page